LONG-TERM INCENTIVE PLAN AWARDS (Tables)

6 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of stock options

						Weighted-
						Average
				Weighted-		Remaining
				Average		Contractual		Aggregate
				Exercise		Life		Intrinsic
Options	Shares			Price		(In Years)		Value
Outstanding as of June 30, 2024		627,001		$	4.24		2.88	$	130,200
Granted		–			–		–		–
Exercised		–			–		–		–
Cancelled		–			–		–		–
Forfeited or expired		(20,000	)		4.90		–		–
Outstanding as of December 31, 2024		607,001		$	4.20		1.40	$	550,240
Exercisable as of December 31, 2024		607,001		$	4.20		1.40	$	550,240

The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based upon the Company’s closing stock price of $4.90 as of December 31, 2024, which would have been received by the option holders had all option holders exercised their options as of that date. The weighted-average grant-date fair value of stock options outstanding as of December 31, 2024, in the amount of 607,001 shares was $3.32 per share. As of December 31, 2024, there was unrecognized compensation cost of $0 related to non-vested stock options granted.

A summary of the status of our stock options is presented below as of December 31, 2023:

						Weighted-
						Average
				Weighted-		Remaining
				Average		Contractual		Aggregate
				Exercise		Life		Intrinsic
Options	Shares			Price		(In Years)		Value
Outstanding as of June 30, 2023		647,001		$	4.24		2.88	$	130,200
Granted		–			–		–		–
Exercised		–			–		–		–
Cancelled		–			–		–		–
Forfeited or expired		(16,000	)		4.77		–		–
Outstanding as of December 31, 2023		631,001		$	4.23		2.38	$	–
Exercisable as of December 31, 2023		509,449		$	4.43		2.24	$	2,454